MaltSci 麦伴科研

Appearance

Popular Reports / Neuroscience

This report is written by MaltSci based on the latest literature and research findings

What are the neural circuits underlying addiction? ​

Abstract ​

Addiction is a chronic brain disease characterized by compulsive engagement in rewarding stimuli despite adverse consequences. Understanding the neural circuits involved in addiction is essential for elucidating its neurobiological basis and developing effective treatments. This report provides a comprehensive overview of the neural circuits implicated in addiction, focusing on the mesolimbic dopamine pathway, prefrontal cortex, and amygdala, which are crucial for reward processing, decision-making, and emotional regulation. The interplay of these circuits, influenced by neurotransmitter systems such as dopamine, serotonin, and norepinephrine, underpins the behavioral manifestations of addiction. Genetic predisposition and environmental factors further complicate the addiction landscape, highlighting the need for a multifaceted approach to treatment. Recent advancements in neuroimaging and optogenetic techniques have enabled researchers to manipulate and observe these circuits with precision, revealing the dynamic interactions that govern addiction. By mapping these specific brain networks, novel targets for pharmacotherapy and circuit-based therapies can be identified, ultimately improving intervention efficacy for substance use disorders. This understanding is paramount for advancing research and developing comprehensive strategies to address the complexities of addiction.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Defining Addiction
    • 2.1 Types of Addictive Substances
    • 2.2 Behavioral vs. Substance Addiction
  • 3 Neural Circuits Involved in Addiction
    • 3.1 The Mesolimbic Dopamine Pathway
    • 3.2 Role of the Prefrontal Cortex
    • 3.3 Involvement of the Amygdala
  • 4 Neurotransmitter Systems in Addiction
    • 4.1 Dopamine and Reward Processing
    • 4.2 Role of Serotonin and Norepinephrine
    • 4.3 Interaction of Endocannabinoid System
  • 5 Factors Influencing Addiction Circuits
    • 5.1 Genetic Predisposition
    • 5.2 Environmental Influences
    • 5.3 Effects of Long-term Substance Use
  • 6 Implications for Treatment and Future Research
    • 6.1 Current Therapeutic Approaches
    • 6.2 Need for Multidisciplinary Strategies
    • 6.3 Future Directions in Addiction Research
  • 7 Conclusion

1 Introduction ​

Addiction is increasingly recognized as a complex neurobiological phenomenon that manifests as a chronic brain disease characterized by compulsive engagement in rewarding stimuli, despite the presence of adverse consequences. This multifaceted condition not only poses significant health risks but also has profound socioeconomic implications globally [1]. The urgency to understand the underlying neural circuits involved in addiction is underscored by the limited efficacy of current treatment options, which often fail to address the intricacies of this disorder. Therefore, elucidating the neurobiological mechanisms that govern addiction is essential for developing effective therapeutic strategies and interventions.

Research into the neural circuits associated with addiction has evolved significantly over the past few decades. Initial studies focused on the role of the mesolimbic dopamine pathway, which is integral to reward processing and motivation [2]. However, contemporary approaches have expanded this understanding to include various brain regions, such as the prefrontal cortex and the amygdala, which are crucial for decision-making and emotional regulation [3][4]. Recent advancements in neuroimaging and optogenetic techniques have enabled researchers to manipulate and observe these neural circuits with unprecedented precision, revealing the dynamic interplay between different brain regions and neurotransmitter systems in addiction [5][6].

The significance of studying these neural circuits lies in their potential to inform future research and treatment approaches. By mapping the specific brain networks involved in addiction, researchers can identify novel targets for pharmacotherapy and circuit-based therapies, ultimately enhancing the efficacy of interventions for substance use disorders (SUDs) [4]. Furthermore, understanding how genetic predisposition, environmental factors, and the effects of long-term substance use impact these circuits can provide critical insights into the etiology of addiction [7][8].

This report is organized to provide a comprehensive overview of the current knowledge surrounding the neural circuits implicated in addiction. The first section will define addiction, distinguishing between various types of addictive substances and behaviors. Following this, we will delve into the specific neural circuits involved in addiction, with a focus on the mesolimbic dopamine pathway, the prefrontal cortex, and the amygdala, elucidating their roles in reward processing, decision-making, and emotional regulation. Subsequently, we will examine the neurotransmitter systems that underpin these circuits, including dopamine, serotonin, and norepinephrine, as well as the interaction with the endocannabinoid system. The report will also address the factors influencing these addiction circuits, such as genetic predisposition, environmental influences, and the effects of long-term substance use. Finally, we will discuss the implications of these findings for treatment and future research, emphasizing the necessity for a multidisciplinary approach to effectively tackle the complexities of addiction.

In summary, understanding the neural circuits underlying addiction is paramount for advancing our knowledge of this chronic condition and developing effective interventions. As we explore the intricate web of interactions among various brain regions and neurotransmitter systems, we hope to illuminate the pathways that lead to addiction and identify potential targets for future therapeutic strategies.

2 Defining Addiction ​

2.1 Types of Addictive Substances ​

Addiction is characterized as a chronic brain disease that significantly impacts health and socio-economic status globally. Understanding the neural circuits underlying addiction is essential for elucidating its neurobiological basis and developing effective treatments. Various brain regions and circuits are implicated in the addictive process, particularly those involved in reward, motivation, and behavioral control.

One of the critical brain areas associated with addiction is the paraventricular thalamic nucleus (PVT). The PVT serves as a key node in the neurocircuits regulating goal-directed behaviors and has been shown to receive extensive inputs from the brainstem and hypothalamus, as well as being reciprocally connected with the limbic system. Neurons in the PVT are activated by drug exposure and cues associated with drug-taking, suggesting its involvement in mediating drug-related behaviors (Zhou & Zhu, 2019) [7].

The nucleus accumbens (NAc) and the ventral tegmental area (VTA) are also central to the addiction circuitry. These areas are integral to the mesolimbic dopamine system, which is crucial for processing reward and motivation. Drug abuse leads to alterations in the activity of these circuits, resulting in compulsive drug-seeking behavior despite negative consequences (Maldonado et al., 2021) [1]. Additionally, the orbitofrontal cortex (OFC) plays a significant role in decision-making and impulse control, with disruptions in this area contributing to the loss of control over drug intake (Goldstein & Volkow, 2011) [3].

Research has indicated that addiction involves an imbalance among three interacting neural systems: an impulsive system primarily dependent on the amygdala and striatum, a reflective system mainly governed by the prefrontal cortex for decision-making and inhibitory control, and the insula, which integrates interoceptive states into conscious feelings and decision-making processes (Noël et al., 2013) [9]. This tripartite model highlights how these neural systems can lead to poor decision-making and increased addiction risk.

In addition to these core areas, the pallidum has been identified as a significant region that integrates associative, sensorimotor, and limbic information, influencing motor responses and habit formation related to addiction behaviors (Campbell & Lobo, 2023) [4]. Furthermore, alterations in striatal circuits have been shown to underlie addiction-like behaviors, emphasizing the importance of understanding the connectivity and regulation of these neural pathways in addiction (Kim et al., 2017) [8].

Overall, the neural circuits underlying addiction encompass a complex interplay between various brain regions, including the PVT, NAc, VTA, OFC, and pallidum, each contributing uniquely to the mechanisms of addiction and the compulsive behaviors associated with it. Understanding these circuits is vital for developing targeted pharmacotherapies and circuit-based interventions for substance use disorders.

2.2 Behavioral vs. Substance Addiction ​

Addiction is characterized by a complex interplay of neural circuits that govern various behaviors associated with compulsive drug seeking and use. Understanding these circuits is essential for unraveling the neurobiological underpinnings of both behavioral and substance addictions.

The primary brain regions implicated in addiction include the mesolimbic dopamine system, which encompasses the ventral tegmental area (VTA) and the nucleus accumbens (NAc). These areas are crucial for processing reward and motivation, and they exhibit altered activity in response to addictive substances, leading to the compulsive behaviors seen in addiction (Joffe et al. 2014). The VTA is responsible for dopamine release, which reinforces behaviors that lead to drug intake, while the NAc integrates signals related to reward and aversion (Maldonado et al. 2021).

Additionally, the paraventricular thalamic nucleus (PVT) has emerged as a significant node within the neural circuits governing addiction. It receives inputs from the brainstem and hypothalamus and is interconnected with the limbic system, playing a role in regulating drug-related behaviors (Zhou & Zhu 2019). Neurons in the PVT are activated not only by drug exposure but also by cues associated with drug use, indicating its involvement in both the pursuit of drugs and the context surrounding their use.

The orbitofrontal cortex (OFC) is another critical area, particularly in its role in decision-making and impulse control. Dysfunction in the OFC has been linked to the inability to resist drug-seeking behaviors despite awareness of negative consequences, highlighting its importance in the cognitive aspects of addiction (Goldstein & Volkow 2011). This area works in concert with the striatum, which is involved in habit formation and the integration of motivational signals, further complicating the neural circuitry involved in addiction (Kim et al. 2017).

Moreover, the pallidum, a region within the basal ganglia, has been identified as a key player in the regulation of addiction-related behaviors. It integrates associative, sensorimotor, and limbic information to shape motor responses and facilitate reward learning, emphasizing its role in the compulsive aspects of drug-seeking behavior (Campbell & Lobo 2023).

Overall, the neural circuits underlying addiction are not only confined to the reward pathways but also encompass regions involved in decision-making, impulse control, and the integration of sensory and emotional information. The interactions among these circuits illustrate the multifaceted nature of addiction, where both behavioral and substance-related dependencies share common neurobiological mechanisms. Understanding these circuits provides critical insights into potential therapeutic targets for addiction treatment, which remains a significant challenge in the field of neuroscience.

3 Neural Circuits Involved in Addiction ​

3.1 The Mesolimbic Dopamine Pathway ​

The mesolimbic dopamine pathway is a critical neural circuit involved in the processes underlying addiction. This pathway is primarily composed of dopaminergic projections from the ventral tegmental area (VTA) to various brain regions, including the nucleus accumbens (NAc) and the prefrontal cortex (PFC). These areas are essential for reward processing, motivation, and the reinforcement of drug-seeking behaviors.

Research indicates that the mesolimbic pathway plays a pivotal role in acute drug reinforcement and the escalation of drug use. Activation of this pathway is associated with the rewarding effects of substances of abuse, which can lead to compulsive drug-seeking behavior despite negative consequences. For instance, studies have shown that drug-associated cues and stress can trigger relapse by activating the mesolimbic dopamine system, which is also influenced by signals from the prefrontal cortex and amygdala[10].

The neurobiological mechanisms of addiction involve both structural and functional adaptations within these circuits. For example, exposure to addictive drugs induces changes in synaptic plasticity within the mesolimbic system, which are thought to contribute to the persistence of addictive behaviors. Drugs of abuse can hijack the synaptic plasticity mechanisms in key brain circuits, particularly in the mesolimbic dopamine system, thereby enhancing the memory of drug experiences and increasing the likelihood of relapse[11].

Additionally, chronic exposure to drugs leads to neuroadaptations in the dopamine signaling pathways. Specifically, alterations in the expression and function of dopamine receptors, particularly D1 and D2 receptors, have been implicated in the pathophysiology of addiction. These adaptations can produce tolerance to the rewarding effects of drugs and increase craving during periods of abstinence[10].

Furthermore, the role of other neurotransmitter systems, such as glutamate and acetylcholine, has also been explored in relation to the mesolimbic pathway. For instance, group II metabotropic glutamate receptors (mGlu2/3) have been shown to regulate dopamine release and are involved in reward processing and drug-seeking behavior. These receptors represent a potential therapeutic target for reducing relapse in addiction[12].

In summary, the mesolimbic dopamine pathway is a central component of the neural circuits involved in addiction, mediating the effects of drugs on reward and motivation. Understanding the intricate neurobiological mechanisms and adaptations within this pathway is crucial for developing effective treatments for addiction and preventing relapse.

3.2 Role of the Prefrontal Cortex ​

The prefrontal cortex (PFC) plays a critical role in addiction, functioning as a key regulator of decision-making, impulse control, memory, and emotional regulation. The involvement of the PFC in addiction is highlighted by its interactions with subcortical reward circuits, including the ventral tegmental area (VTA) and nucleus accumbens (NAc), which are integral to the brain's reward system. Specifically, the PFC has projections to the lateral habenula (LHb), a region essential for encoding negative reward signals and modulating the reward system. Recent studies have demonstrated that the PFC-LHb circuit significantly influences cocaine-related behaviors. For instance, optogenetic stimulation of this circuit during cocaine conditioning abolished cocaine preference without inducing aversion, suggesting its pivotal role in regulating cocaine reward-related behaviors [13].

Moreover, neuroimaging studies have shown that dysfunctions in the PFC contribute to the loss of control over drug intake observed in addiction. Initially, it was believed that addiction primarily resulted from disruptions in subcortical reward circuits. However, emerging evidence indicates that the PFC's regulation of limbic reward regions and its involvement in higher-order executive functions are crucial to understanding addiction. For example, studies have revealed that alterations in PFC function underlie compulsive drug-seeking behaviors and disadvantageous decision-making associated with addiction [3].

The PFC's role extends to regulating inhibitory control over drug use, a critical aspect of addiction. Dysregulation within frontostriatal circuits, which connect the PFC with the striatum, has been linked to increased difficulty in ceasing drug use. Recent findings suggest that these circuits are involved in the cognitive deficits seen in individuals with substance use disorders, emphasizing the importance of targeting these impairments in treatment strategies [14].

Functional connectivity studies have further elucidated the specific PFC circuits associated with addiction. For instance, research identified distinct dorsolateral prefrontal cortex (dlPFC) circuits that predict cocaine relapse with high accuracy. These circuits are implicated in both 'bottom-up' drives to use drugs and 'top-down' control over behavior, as well as in social-emotional processing [15]. This highlights the complexity of the PFC's involvement in addiction, suggesting that different loci within the PFC may serve as potential neuromodulation targets for addiction treatment [15].

Overall, the PFC is integral to the neural circuitry underlying addiction, influencing both the cognitive and emotional processes that govern drug-seeking behaviors. Understanding the specific roles of PFC circuits in addiction can provide valuable insights for developing targeted interventions aimed at treating substance use disorders.

3.3 Involvement of the Amygdala ​

Addiction is a complex condition that involves multiple neural circuits, with the amygdala playing a critical role in the mechanisms of addiction. The amygdala is deeply involved in the processing of emotions, reward, and associative learning, which are all pivotal in the context of addiction.

Research has extensively highlighted the involvement of the amygdala, particularly the basolateral amygdala (BLA), in the associative learning processes that underpin drug addiction and relapse. For instance, See et al. (2003) demonstrated that the BLA is crucial for the conditioned-cued reinstatement of drug-seeking behavior. In their study, rats that had undergone chronic cocaine self-administration exhibited reinstatement of extinguished lever pressing for conditioned stimuli previously paired with cocaine, a behavior that was attenuated by lesions or pharmacological inactivation of the BLA [16]. This suggests that the BLA is integral to the acquisition and expression of drug-seeking behaviors, particularly those elicited by drug-associated cues.

Moreover, the amygdala's response to emotionally salient stimuli has been shown to enhance memory for these stimuli, which can strengthen the associations between drug cues and drug-seeking behavior. Jasinska et al. (2012) found that the amygdala's response to smoking-cessation messages predicted quitting outcomes in smokers, indicating that genetic variations can modulate this response and subsequently affect addiction behaviors [17]. This highlights the amygdala's dual role in both facilitating addiction and providing pathways for potential cessation.

Additionally, the interaction between the amygdala and other brain regions, such as the prefrontal cortex (PFC) and nucleus accumbens (NAc), is vital for understanding addiction. The amygdala communicates bi-directionally with these areas, which are involved in cognition, motivation, and stress responses. Sharp (2017) emphasized that dysregulation within these circuits, particularly in the BLA, can lead to behavioral disturbances characteristic of addiction, such as heightened drug-seeking behaviors and impaired decision-making [18].

Furthermore, neuroadaptive changes in the amygdala have been linked to the development of drug dependence. Koob (2003) discussed how alterations in neurochemical mechanisms within the extended amygdala, including changes in neurotransmitters like dopamine and GABA, contribute to the negative motivational states that drive addiction [19]. These neuroadaptive changes reflect a shift from a homeostatic to an allostatic state, indicating a long-term alteration in reward processing.

In summary, the amygdala is a central component of the neural circuits involved in addiction, influencing both the acquisition of drug-seeking behaviors and the emotional responses associated with these behaviors. Its interactions with other brain regions and the neuroadaptive changes that occur during addiction underscore the complexity of this condition and the critical role of the amygdala in both the pathology of addiction and potential avenues for treatment.

4 Neurotransmitter Systems in Addiction ​

4.1 Dopamine and Reward Processing ​

Addiction is fundamentally linked to specific neural circuits that are involved in reward processing. Central to this understanding is the mesolimbic dopamine pathway, which includes critical regions such as the ventral tegmental area (VTA) and the nucleus accumbens (NAc). The circuitry underlying addiction has been characterized by complex interactions among various neurotransmitters, with dopamine playing a pivotal role in mediating the rewarding effects of drugs and behaviors.

The mesocorticolimbic dopamine pathway is well established as a key player in drug reward mechanisms. Dopamine release in the NAc is particularly significant during drug exposure, reinforcing the behaviors associated with drug seeking and consumption. However, recent studies indicate that other neurotransmitters, including serotonin, glutamate, and endorphins, also contribute to the neurobiological mechanisms of addiction. For instance, alterations in glutamatergic transmission within the prefrontal cortex and its projections to the NAc have been implicated in the compulsive nature of drug-seeking behaviors (Kalivas & Volkow, 2005; Joffe et al., 2014) [2][20].

Research has demonstrated that the adaptations in these neurotransmitter systems are not merely peripheral but involve significant changes at the synaptic and structural levels. For example, the activation of glutamatergic pathways has been shown to decrease the capacity of the prefrontal cortex to exert control over drug-seeking behaviors, leading to a diminished ability to respond to natural rewards (Kalivas & Volkow, 2005). This is compounded by the hyperresponsiveness of the prefrontal cortex to drug-related cues, which enhances the motivational drive for drug acquisition (Kalivas & Volkow, 2005).

Furthermore, the interplay between dopamine and other neurotransmitters within the reward circuitry suggests that understanding these interactions could provide insights into therapeutic targets for addiction treatment. The involvement of serotonin and glutamate in behavioral addiction emphasizes the need for a broader view of addiction that transcends the classical dopamine-centric models. This includes considering how these neurotransmitters interact within the reward circuitry, which could lead to more effective interventions (Peng et al., 2024) [21].

In summary, the neural circuits underlying addiction are complex and involve a network of interactions primarily centered around the mesolimbic dopamine pathway, but also incorporating other neurotransmitter systems. These interactions contribute to the behavioral manifestations of addiction, such as compulsive drug-seeking and the altered processing of rewards. Understanding these circuits and their neurobiological underpinnings is crucial for developing targeted therapies aimed at treating addiction and its related disorders.

4.2 Role of Serotonin and Norepinephrine ​

Addiction is a complex neurobiological disorder characterized by compulsive drug-seeking behavior and loss of control over drug use. The underlying neural circuits involved in addiction encompass a range of neurotransmitter systems, particularly focusing on dopamine, serotonin, and norepinephrine, which play critical roles in the manifestation of addictive behaviors.

The limbic system, a central player in the neurochemical basis of addiction, includes key brain areas such as the ventral tegmentum, nucleus accumbens, locus ceruleus, dorsal raphe nuclei, and periaqueductal gray area. These regions contain cell bodies and receptors for neurotransmitters like dopamine, norepinephrine, serotonin, and endogenous opiates, which are modulated during addictive behaviors (Miller & Gold, 1993) [22].

Dopamine is particularly significant in the mesolimbic pathway, which is involved in the reward system. This pathway becomes dysregulated during addiction, leading to compulsive drug use and a cycle of spiraling dysregulation of brain reward systems (Koob & Le Moal, 1997) [23]. The interaction between dopamine and stress systems, including norepinephrine, is crucial as activation of these stress systems is hypothesized to contribute to the negative emotional states that drive drug-seeking behavior through negative reinforcement mechanisms (Koob, 2008) [24].

Serotonin, another critical neurotransmitter, is implicated in the modulation of mood and impulsivity. Recent neuroimaging studies have indicated that alterations in the serotonin system may influence addiction-related behaviors. For instance, research has shown that dysfunction of the dopamine system can both arise from and contribute to stimulant use, mediated by the capacity of individuals to exert inhibitory control over their behaviors (Groman & Jentsch, 2013) [25]. Furthermore, differences in serotonin transporter density have been observed in individuals with behavioral addictions such as binge eating disorder and pathological gambling, suggesting distinct neurobiological underpinnings that could inform treatment strategies (Majuri et al., 2017) [26].

In summary, the neural circuits underlying addiction are characterized by a complex interplay of various neurotransmitter systems, particularly dopamine, serotonin, and norepinephrine. These systems interact within the limbic circuitry, influencing reward processing, emotional regulation, and behavioral control, thereby contributing to the development and maintenance of addictive behaviors. Understanding these neural mechanisms is crucial for identifying potential therapeutic targets for addiction treatment.

4.3 Interaction of Endocannabinoid System ​

The endocannabinoid system plays a significant role in the neural circuits associated with addiction, particularly in the modulation of reward pathways. It interacts with various neurotransmitter systems, influencing the processes underlying addiction behaviors. The primary brain regions implicated in these mechanisms include the ventral tegmental area (VTA), nucleus accumbens (NAc), and medial prefrontal cortex (mPFC), which are crucial components of the brain's reward circuitry.

Cannabinoids, such as Δ9-tetrahydrocannabinol, exert their effects through cannabinoid type 1 (CB1) receptors, which are densely located in the VTA and NAc. Activation of these receptors enhances dopamine release, which is a key neurotransmitter in the reward pathway. This increase in dopamine levels contributes to the reinforcing properties of addictive substances, including cannabinoids themselves, thereby promoting drug-seeking behavior and the development of dependence [27].

Moreover, the endocannabinoid system is involved in the modulation of synaptic plasticity, which is critical for learning and memory processes related to addiction. Endocannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), facilitate retrograde signaling at both GABAergic and glutamatergic synapses, influencing dopaminergic neuron activity. For instance, in the VTA, endocannabinoids can modulate the activity of dopaminergic neurons, thereby affecting the synaptic inputs they receive and altering reward-related signaling [28].

Additionally, the interaction between endocannabinoids and other neurotransmitter systems, such as the dopaminergic system, is crucial in understanding the neurobiological mechanisms of addiction. Studies have shown that cocaine, a commonly abused substance, increases endocannabinoid levels in the striatum, which is involved in compulsive drug-seeking behaviors. This effect is mediated through dopamine D2-like receptors, highlighting the interconnectedness of the endocannabinoid and dopaminergic systems in the context of addiction [29].

The role of the endocannabinoid system extends beyond mere modulation of dopamine release; it also influences emotional states and stress responses, which are significant factors in addiction. Dysregulation of endocannabinoid signaling can lead to heightened stress reactivity and negative affective states, further perpetuating the cycle of addiction [30].

In summary, the neural circuits underlying addiction involve complex interactions between the endocannabinoid system and various neurotransmitter systems, particularly the dopaminergic pathways. The VTA, NAc, and mPFC serve as central hubs in this circuitry, where endocannabinoids modulate synaptic transmission and influence behaviors related to reward and reinforcement. Understanding these interactions is essential for developing therapeutic strategies aimed at treating addiction and preventing relapse.

5 Factors Influencing Addiction Circuits ​

5.1 Genetic Predisposition ​

Addiction is characterized by compulsive drug-seeking behavior and is influenced by a complex interplay of neural circuits, genetic predisposition, and environmental factors. The understanding of the neural circuits involved in addiction has advanced significantly, particularly in relation to the mesolimbic dopamine system, which includes key structures such as the nucleus accumbens and the ventral tegmental area (VTA). These regions are critical for the manifestation of addiction-related behaviors, as they are heavily involved in reward processing and motivation.

Imaging studies have revealed that individual variations in dopamine-modulated brain circuits contribute to differences in addiction vulnerability. These circuits are involved in reward, memory, executive function, and motivation, suggesting that alterations in their function can influence the risk of developing substance use disorders (Volkow et al., 2012)[31]. Chronic drug use has been shown to disrupt the normal functioning of these circuits, leading to maladaptive changes that promote compulsive behaviors (Stuber et al., 2012)[6].

Genetic factors also play a crucial role in shaping individual differences in addiction vulnerability. Addictive disorders have a heritable component, with twin studies indicating that the heritability of addictions can range from 0.39 for hallucinogens to 0.72 for cocaine (Ducci & Goldman, 2012)[32]. Genetic variants, particularly those affecting dopamine signaling, have been associated with variations in the sensitivity of reward-related circuits. For instance, polymorphisms in the DRD2 and DAT1 genes have been linked to impulsivity and reward circuitry activation, which may contribute to nicotine dependence (Sweitzer et al., 2012)[33].

The integration of genetic and neurobiological findings has led to the development of models that explore how genetic predispositions interact with environmental factors to influence addiction outcomes. The Genetically Informed Neurobiology of Addiction (GINA) model proposes that substance-induced changes in neural circuitry promote the progression of addiction, highlighting the importance of understanding both genetic and neurobiological underpinnings in addressing addiction (Bogdan et al., 2023)[34].

In summary, the neural circuits underlying addiction are primarily centered around the mesolimbic dopamine system, with significant involvement from the nucleus accumbens and VTA. Genetic predispositions, particularly those related to dopamine signaling, interact with these circuits to influence individual vulnerability to addiction. Understanding these complex interactions is crucial for developing effective prevention and treatment strategies for substance use disorders.

5.2 Environmental Influences ​

Addiction is fundamentally a chronic brain disease characterized by the compulsive pursuit of drugs or behaviors despite adverse consequences. Understanding the neural circuits underlying addiction is crucial for developing effective prevention and treatment strategies. Several key factors influence these addiction circuits, including genetic, developmental, environmental, and neurobiological mechanisms.

The primary neural circuits involved in addiction include those associated with the brain's reward system, particularly the mesolimbic pathway, which encompasses the nucleus accumbens and the ventral tegmental area. These areas are integral to the processing of rewarding stimuli and the regulation of motivated behavior. Repeated exposure to addictive substances can lead to significant alterations in the connectivity and function of these circuits, resulting in changes in behavior and increased vulnerability to addiction. For instance, drugs of abuse hijack the reward circuit, producing intense activation that modifies future behavior to seek similar stimuli, as noted by MacNicol (2017), who emphasizes the role of neurobiological mechanisms that promote ongoing use and relapse in addiction[35].

Environmental influences play a significant role in modulating the vulnerability to addiction. Volkow et al. (2012) highlight that individual variations in key dopamine-modulated brain circuits, which are involved in reward, memory, executive function, and motivation, contribute to differences in addiction vulnerability[31]. Social stressors, developmental trajectories, and genetic background can affect these circuits, underscoring the complexity of addiction as a multifactorial condition. The interaction between these environmental factors and the brain's neurobiology can exacerbate or mitigate the risk of developing addiction, indicating that the context in which substance use occurs is critical to understanding addiction dynamics.

Moreover, recent advances in experimental techniques such as DREADDs, calcium imaging, and electrophysiology have facilitated a deeper understanding of the specific neural circuits involved in addiction. Maldonado et al. (2021) summarize the significance of these innovative approaches in elucidating the neurobiological basis of addiction and how they can inform the development of novel treatment strategies[1]. The ability to target specific brain regions and manipulate their activity has provided valuable insights into the mechanisms underlying addiction-like behaviors and has the potential to identify effective interventions.

In summary, the neural circuits underlying addiction are influenced by a complex interplay of genetic, developmental, and environmental factors. The mesolimbic pathway, particularly the interactions between the nucleus accumbens and ventral tegmental area, plays a central role in the reward circuitry associated with addiction. Understanding how these circuits are affected by external factors is crucial for developing comprehensive strategies for preventing and treating substance-use disorders.

5.3 Effects of Long-term Substance Use ​

Addiction is a complex brain disorder characterized by compulsive drug-seeking behavior and the persistence of drug use despite negative consequences. Understanding the neural circuits involved in addiction is crucial for elucidating the mechanisms that contribute to this chronic condition.

The primary neural circuits implicated in addiction involve the mesocorticolimbic pathway, which includes key brain structures such as the ventral tegmental area (VTA), nucleus accumbens (NAc), amygdala, and prefrontal cortex. These regions are integral to the reward circuitry and play significant roles in the reinforcing effects of drugs of abuse. Activation of dopaminergic pathways originating from the VTA leads to the release of dopamine in the NAc, which is associated with the pleasurable effects of drugs, thereby reinforcing drug-seeking behavior (Feltenstein & See, 2008; Joffe et al., 2014).

Long-term substance use induces profound changes in these neural circuits, resulting in alterations that contribute to addiction. Chronic exposure to drugs can lead to functional neurotoxicity, which refers to long-lasting dysfunctions in neurons associated with the brain's reward systems. This dysfunction may enhance vulnerability to relapse and sustained drug dependence (Weiss & Koob, 2001). Specifically, the extended amygdala, which encompasses parts of the NAc and amygdala, is crucial for mediating both the acute reinforcing effects of drugs and the negative emotional states associated with withdrawal (Koob, 2000).

The transition from casual drug use to compulsive behavior is influenced by various factors, including genetic predisposition, environmental triggers, and the timing and frequency of substance exposure. These factors can alter the brain's reward circuitry, leading to an allostatic state where the normal set point for reward is shifted, increasing the drive for drug-seeking behavior (Kalivas & O'Brien, 2008; MacNicol, 2017).

Neural plasticity plays a significant role in the pathophysiology of addiction. Repeated drug exposure can result in structural and functional changes within the neural circuits, including synaptic modifications and altered gene expression. These changes are believed to underlie the compulsive nature of addiction and the persistence of drug-seeking behavior even after prolonged abstinence (Kim et al., 2017; Zhou & Zhu, 2019).

In summary, the neural circuits underlying addiction are primarily located within the mesocorticolimbic system, with critical contributions from various brain regions that regulate reward and motivation. Long-term substance use leads to significant neuroadaptive changes that promote compulsive drug-seeking behavior, highlighting the need for continued research into these mechanisms to develop effective therapeutic interventions for addiction (Maldonado et al., 2021; Taylor et al., 2013).

6 Implications for Treatment and Future Research ​

6.1 Current Therapeutic Approaches ​

Addiction is a complex and chronic brain disease characterized by compulsive drug seeking and use despite adverse consequences. Understanding the neural circuits involved in addiction is crucial for developing effective treatments and advancing future research. Several key brain regions and their interactions form the neural circuits underlying addiction.

The paraventricular thalamic nucleus (PVT) has emerged as a significant hub within the neural circuits that regulate drug-related behaviors. The PVT receives extensive inputs from the brainstem and hypothalamus and is reciprocally connected with the limbic system. Research indicates that neurons in the PVT are activated by drug exposure and associated cues, suggesting its role in controlling goal-directed behaviors related to addiction (Zhou & Zhu, 2019) [7]. Furthermore, alterations in striatal circuits, particularly within the striatum—a key area for dopamine transmission—are central to addiction-like behaviors. The striatum integrates glutamate, GABA, and dopamine signaling, influencing stereotyped behaviors associated with drug use (Kim et al., 2017) [8].

The addiction cycle is often described in three stages: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation (craving). Each stage is linked to specific neurocircuits, including the basal ganglia, extended amygdala, and frontal cortex, which are involved in reward processing and stress responses (Koob & Mason, 2016) [36]. The loss of control over drug intake is partly attributed to disruptions in these circuits, particularly in the prefrontal cortex (PFC), which is essential for self-control and decision-making (Goldstein & Volkow, 2011) [3].

Current therapeutic approaches for addiction often target these neural circuits, aiming to restore balance and functionality. Pharmacotherapies are being developed to modulate the activity of specific neurotransmitter systems implicated in addiction, such as dopamine and GABAergic pathways. Moreover, innovative techniques like optogenetics and in vivo imaging have been employed to manipulate and observe neural circuit activity, providing insights into the specific mechanisms driving addiction behaviors (Vickstrom et al., 2022) [5].

Future research directions include the exploration of circuit-specific mechanisms and the potential for personalized medicine approaches in treating addiction. Understanding the interactions between the impulsive and reflective neural systems involved in addiction, as well as their role in decision-making processes, could lead to more effective interventions (Noël et al., 2013) [9]. Continued advancements in neuroimaging and circuit manipulation technologies will enhance our ability to identify and target the neural substrates of addiction, ultimately leading to improved treatment outcomes.

In summary, the neural circuits underlying addiction encompass a network of brain regions that regulate reward, motivation, and self-control. The integration of behavioral models with advanced neuroscientific techniques will be essential for elucidating the complexities of addiction and developing effective therapeutic strategies.

6.2 Need for Multidisciplinary Strategies ​

Addiction is a complex brain disease characterized by compulsive drug-seeking behavior and the persistence of such behavior despite adverse consequences. The neurobiological underpinnings of addiction involve various neural circuits that regulate reward, motivation, and behavior. Understanding these circuits is crucial for developing effective treatments and future research directions.

The paraventricular thalamic nucleus (PVT) has emerged as a key hub in the neural circuits associated with drug addiction. It integrates inputs from the brainstem and hypothalamus and connects with the limbic system, influencing goal-directed behaviors. Research indicates that neurons in the PVT are activated by drug exposure and associated cues, suggesting its significant role in mediating drug-related behaviors (Zhou & Zhu, 2019) [7].

Additionally, the striatum, a central component of the reward system, plays a vital role in addiction. It is the primary area for glutamate, GABA, and dopamine transmission, which are crucial for determining stereotyped behaviors. Alterations in the striatal circuits following repeated drug exposure contribute to addiction-like behaviors, highlighting the need to understand how these changes in connectivity affect the expression of such behaviors (Kim et al., 2017) [8].

Recent advancements in neuroimaging and optogenetic techniques have provided insights into the specific neural circuits involved in addiction. For instance, optogenetics allows for the selective modulation of genetically defined neuronal populations, enabling researchers to delineate the relationships between circuit function and addictive behaviors. This approach has been particularly valuable in studying the connectivity within the ventral tegmental area and the nucleus accumbens, which are critical for addiction-related behaviors (Stuber et al., 2012) [6].

The interplay between different neural systems is also crucial for understanding addiction. A neurocognitive model posits that addiction arises from an imbalance among three interacting neural systems: an impulsive system primarily dependent on the amygdala and striatum, a reflective system associated with the prefrontal cortex, and an insular system that integrates interoceptive states into decision-making processes. This model highlights the importance of understanding how these systems contribute to poor decision-making and increased addiction risk (Noël et al., 2013) [9].

Given the complexity of addiction and its underlying neural circuits, multidisciplinary strategies are essential for advancing research and treatment. Combining behavioral studies with cutting-edge neurobiological techniques can enhance our understanding of the addiction process. Furthermore, insights gained from these approaches can inform the development of novel pharmacotherapies that target specific neural circuits involved in addiction, potentially alleviating the burden of this chronic disorder (Koob & Mason, 2016) [36].

In conclusion, the neural circuits underlying addiction are intricate and involve various brain regions, including the PVT, striatum, and prefrontal cortex. The integration of innovative experimental techniques and multidisciplinary approaches will be critical for elucidating the mechanisms of addiction and developing effective treatment strategies. Understanding these circuits not only provides a foundation for targeted therapies but also offers opportunities for advancing the field of addiction research as a whole.

6.3 Future Directions in Addiction Research ​

Addiction is a complex brain disease characterized by compulsive drug-seeking behavior and significant neurobiological alterations. Understanding the neural circuits underlying addiction is critical for developing effective treatments and informing future research directions.

Several key brain regions and circuits have been identified as integral to the addiction process. The paraventricular thalamic nucleus (PVT) has emerged as a crucial hub in the neural circuits that regulate drug-related behaviors. The PVT is extensively connected with the brainstem, hypothalamus, and limbic system, playing a significant role in goal-directed behaviors associated with addiction. Recent studies have shown that neurons in the PVT are activated by drug exposure and cues associated with drug use, highlighting its involvement in the addictive process (Zhou & Zhu, 2019) [7].

The striatum, particularly the nucleus accumbens, is another vital area in the reward circuitry involved in addiction. It serves as a convergence point for glutamate, GABA, and dopamine transmission, influencing stereotyped behaviors related to drug use. Alterations in the connectivity and regulation of striatal circuits following repeated drug exposure are believed to contribute to addiction-like behaviors, indicating the striatum's pivotal role in mediating the compulsive aspects of addiction (Kim et al., 2017) [8].

Moreover, the pallidum, a region within the basal ganglia, integrates associative, sensorimotor, and limbic information, which is essential for shaping motor responses and regulating habit formation. Recent findings suggest that specific circuits within the pallidum are crucial for driving addiction-related behaviors, emphasizing the need to explore these circuit-specific mechanisms in substance use disorder (Campbell & Lobo, 2023) [4].

The prefrontal cortex (PFC) has also been identified as a critical area in addiction, particularly concerning self-control and decision-making. Imaging studies have revealed that dysfunction in the PFC is associated with the loss of control over drug intake and contributes to the behavioral disadvantages observed in individuals with addiction (Goldstein & Volkow, 2011) [3].

Future directions in addiction research should focus on several key areas. First, there is a need for continued exploration of the specific neural circuits involved in addiction to enhance our understanding of the disease's neurobiological basis. Innovative experimental techniques, such as optogenetics and in vivo imaging, provide powerful tools for manipulating and observing neural activity in addiction-related contexts, which could yield significant insights into the underlying mechanisms of addiction (Vickstrom et al., 2022) [5].

Additionally, integrating knowledge from different levels of analysis, including molecular, cellular, and circuit levels, will be essential for developing targeted therapeutic interventions. Understanding the neuroplastic changes that occur in response to addictive substances can inform the development of pharmacotherapies aimed at reversing the maladaptive alterations in neural circuits associated with addiction (Kalivas & O'Brien, 2008) [37].

In summary, the neural circuits underlying addiction involve a complex interplay of various brain regions, including the PVT, striatum, pallidum, and PFC. Future research should leverage advanced technologies to dissect these circuits further and explore their implications for developing effective treatments for addiction.

7 Conclusion ​

The exploration of neural circuits underlying addiction has revealed critical insights into the neurobiological mechanisms that drive this complex condition. Key findings indicate that the mesolimbic dopamine pathway, along with the prefrontal cortex and amygdala, plays significant roles in reward processing, decision-making, and emotional regulation, all of which are essential for understanding addiction behaviors. Current research highlights the importance of the paraventricular thalamic nucleus and striatal circuits in mediating drug-seeking behaviors, while genetic and environmental factors further influence individual vulnerability to addiction. As the field advances, there is a growing recognition of the need for multidisciplinary approaches that integrate behavioral, genetic, and neurobiological perspectives to develop targeted therapies. Future research should focus on circuit-specific mechanisms and the interactions between different neurotransmitter systems to create more effective interventions for substance use disorders. The integration of innovative technologies and a deeper understanding of the neuroplastic changes associated with addiction will be pivotal in shaping future treatment strategies, ultimately enhancing outcomes for individuals struggling with addiction.

References ​

  • [1] R Maldonado;P Calvé;A García-Blanco;L Domingo-Rodriguez;E Senabre;E Martín-García. Vulnerability to addiction.. Neuropharmacology(IF=4.6). 2021. PMID:33482225. DOI: 10.1016/j.neuropharm.2021.108466.
  • [2] Max E Joffe;Carrie A Grueter;Brad A Grueter. Biological substrates of addiction.. Wiley interdisciplinary reviews. Cognitive science(IF=3.8). 2014. PMID:24999377. DOI: 10.1002/wcs.1273.
  • [3] Rita Z Goldstein;Nora D Volkow. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.. Nature reviews. Neuroscience(IF=26.7). 2011. PMID:22011681. DOI: 10.1038/nrn3119.
  • [4] Rianne R Campbell;Mary Kay Lobo. Pallidal circuits drive addiction behavior.. Trends in neurosciences(IF=15.1). 2023. PMID:39492310. DOI: 10.1016/j.tins.2023.10.001.
  • [5] Casey R Vickstrom;Shana Terai Snarrenberg;Vladislav Friedman;Qing-Song Liu. Application of optogenetics and in vivo imaging approaches for elucidating the neurobiology of addiction.. Molecular psychiatry(IF=10.1). 2022. PMID:34145393. DOI: 10.1038/s41380-021-01181-3.
  • [6] Garret D Stuber;Jonathan P Britt;Antonello Bonci. Optogenetic modulation of neural circuits that underlie reward seeking.. Biological psychiatry(IF=9.0). 2012. PMID:22196983. DOI: 10.1016/j.biopsych.2011.11.010.
  • [7] Kuikui Zhou;Yingjie Zhu. The paraventricular thalamic nucleus: A key hub of neural circuits underlying drug addiction.. Pharmacological research(IF=10.5). 2019. PMID:30772461. DOI: 10.1016/j.phrs.2019.02.014.
  • [8] Hyun Jin Kim;Joo Han Lee;Kyunghwa Yun;Joung-Hun Kim. Alterations in Striatal Circuits Underlying Addiction-Like Behaviors.. Molecules and cells(IF=6.5). 2017. PMID:28724279. DOI: 10.14348/molcells.2017.0088.
  • [9] Xavier Noël;Damien Brevers;Antoine Bechara. A neurocognitive approach to understanding the neurobiology of addiction.. Current opinion in neurobiology(IF=5.2). 2013. PMID:23395462. DOI: .
  • [10] D W Self. Neural substrates of drug craving and relapse in drug addiction.. Annals of medicine(IF=4.3). 1998. PMID:9783837. DOI: 10.3109/07853899809029938.
  • [11] Julie A Kauer;Robert C Malenka. Synaptic plasticity and addiction.. Nature reviews. Neuroscience(IF=26.7). 2007. PMID:17948030. DOI: 10.1038/nrn2234.
  • [12] Khaled Moussawi;Peter W Kalivas. Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.. European journal of pharmacology(IF=4.7). 2010. PMID:20371233. DOI: 10.1016/j.ejphar.2010.01.030.
  • [13] Nur Abdel-Hay;Marina Kabirova;Rami Yaka. A discrete subpopulation of PFC-LHb neurons govern cocaine place preference.. Translational psychiatry(IF=6.2). 2024. PMID:38956048. DOI: 10.1038/s41398-024-02988-8.
  • [14] Jodie Feil;Dianne Sheppard;Paul B Fitzgerald;Murat Yücel;Dan I Lubman;John L Bradshaw. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control.. Neuroscience and biobehavioral reviews(IF=7.9). 2010. PMID:20223263. DOI: 10.1016/j.neubiorev.2010.03.001.
  • [15] Tianye Zhai;Betty Jo Salmeron;Hong Gu;Bryon Adinoff;Elliot A Stein;Yihong Yang. Functional connectivity of dorsolateral prefrontal cortex predicts cocaine relapse: implications for neuromodulation treatment.. Brain communications(IF=4.5). 2021. PMID:34189458. DOI: 10.1093/braincomms/fcab120.
  • [16] Ronald E See;Rita A Fuchs;Christopher C Ledford;Joselyn McLaughlin. Drug addiction, relapse, and the amygdala.. Annals of the New York Academy of Sciences(IF=4.8). 2003. PMID:12724166. DOI: 10.1111/j.1749-6632.2003.tb07089.x.
  • [17] Agnes J Jasinska;Hannah Faye Chua;S Shaun Ho;Thad A Polk;Laura S Rozek;Victor J Strecher. Amygdala response to smoking-cessation messages mediates the effects of serotonin transporter gene variation on quitting.. NeuroImage(IF=4.5). 2012. PMID:22245645. DOI: 10.1016/j.neuroimage.2011.12.064.
  • [18] B M Sharp. Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction.. Translational psychiatry(IF=6.2). 2017. PMID:28786979. DOI: 10.1038/tp.2017.161.
  • [19] George F Koob. Neuroadaptive mechanisms of addiction: studies on the extended amygdala.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology(IF=6.7). 2003. PMID:14636960. DOI: 10.1016/j.euroneuro.2003.08.005.
  • [20] Peter W Kalivas;Nora D Volkow. The neural basis of addiction: a pathology of motivation and choice.. The American journal of psychiatry(IF=14.7). 2005. PMID:16055761. DOI: 10.1176/appi.ajp.162.8.1403.
  • [21] Zhenlei Peng;Qiyu Jia;Junxiong Mao;Xiao Luo;Anqi Huang;Hao Zheng;Shijie Jiang;Qi Ma;Chuang Ma;Qizhong Yi. Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction.. Frontiers in psychiatry(IF=3.2). 2024. PMID:39876994. DOI: 10.3389/fpsyt.2024.1439727.
  • [22] N S Miller;M S Gold. A hypothesis for a common neurochemical basis for alcohol and drug disorders.. The Psychiatric clinics of North America(IF=3.4). 1993. PMID:8456036. DOI: .
  • [23] G F Koob;M Le Moal. Drug abuse: hedonic homeostatic dysregulation.. Science (New York, N.Y.)(IF=45.8). 1997. PMID:9311926. DOI: 10.1126/science.278.5335.52.
  • [24] George F Koob. A role for brain stress systems in addiction.. Neuron(IF=15.0). 2008. PMID:18614026. DOI: 10.1016/j.neuron.2008.06.012.
  • [25] Stephanie M Groman;J David Jentsch. Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.. Current opinion in neurobiology(IF=5.2). 2013. PMID:23528268. DOI: .
  • [26] Joonas Majuri;Juho Joutsa;Jarkko Johansson;Valerie Voon;Riitta Parkkola;Hannu Alho;Eveliina Arponen;Valtteri Kaasinen. Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [11C]MADAM.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology(IF=6.7). 2017. PMID:29032922. DOI: 10.1016/j.euroneuro.2017.09.007.
  • [27] Rainer Spanagel. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.. Dialogues in clinical neuroscience(IF=8.9). 2020. PMID:33162767. DOI: 10.31887/DCNS.2020.22.3/rspanagel.
  • [28] Ferenc Mátyás;Gabriella M Urbán;Masahiko Watanabe;Ken Mackie;Andreas Zimmer;Tamás F Freund;István Katona. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.. Neuropharmacology(IF=4.6). 2008. PMID:17655884. DOI: 10.1016/j.neuropharm.2007.05.028.
  • [29] Diego Centonze;Natalia Battista;Silvia Rossi;Nicola B Mercuri;Alessandro Finazzi-Agrò;Giorgio Bernardi;Paolo Calabresi;Mauro Maccarrone. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology(IF=7.1). 2004. PMID:15100701. DOI: 10.1038/sj.npp.1300458.
  • [30] Antonia Serrano;Loren H Parsons. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.. Pharmacology & therapeutics(IF=12.5). 2011. PMID:21798285. DOI: 10.1016/j.pharmthera.2011.06.005.
  • [31] Nora D Volkow;Gene-Jack Wang;Joanna S Fowler;Dardo Tomasi. Addiction circuitry in the human brain.. Annual review of pharmacology and toxicology(IF=13.1). 2012. PMID:21961707. DOI: 10.1146/annurev-pharmtox-010611-134625.
  • [32] Francesca Ducci;David Goldman. The genetic basis of addictive disorders.. The Psychiatric clinics of North America(IF=3.4). 2012. PMID:22640768. DOI: 10.1016/j.psc.2012.03.010.
  • [33] Maggie M Sweitzer;Eric C Donny;Ahmad R Hariri. Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.. Drug and alcohol dependence(IF=3.6). 2012. PMID:22342427. DOI: 10.1016/j.drugalcdep.2012.01.017.
  • [34] Ryan Bogdan;Alexander S Hatoum;Emma C Johnson;Arpana Agrawal. The Genetically Informed Neurobiology of Addiction (GINA) model.. Nature reviews. Neuroscience(IF=26.7). 2023. PMID:36446900. DOI: 10.1038/s41583-022-00656-8.
  • [35] Brent MacNicol. The biology of addiction.. Canadian journal of anaesthesia = Journal canadien d'anesthesie(IF=3.3). 2017. PMID:27837404. DOI: 10.1007/s12630-016-0771-2.
  • [36] George F Koob;Barbara J Mason. Existing and Future Drugs for the Treatment of the Dark Side of Addiction.. Annual review of pharmacology and toxicology(IF=13.1). 2016. PMID:26514207. DOI: 10.1146/annurev-pharmtox-010715-103143.
  • [37] Peter W Kalivas;Charles O'Brien. Drug addiction as a pathology of staged neuroplasticity.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology(IF=7.1). 2008. PMID:17805308. DOI: 10.1038/sj.npp.1301564.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Addiction · Neural Circuits · Dopamine Pathway · Prefrontal Cortex · Emotional Regulation

© 2025 MaltSci